Navigation Links
New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
Date:9/12/2007

already approved for the treatment of complicated skin and soft tissue infections (cSSTI) caused by Staphylococcus aureus and other Gram positive bacteria, including MRSA.(1) Clinical trials in cSSTI showed daptomycin had a faster time to cure (63% of patients successfully treated with daptomycin achieved a clinical cure within four to seven days versus 33% with comparators such as vancomyin and anti-staphylococcal penicillins).(6)

Pivotal trial data published in The New England Journal of Medicine supports the use of daptomycin in the treatment of bacteraemia and endocarditis caused by MRSA. The head-to-head study demonstrated daptomycin single agent therapy was as effective as dual agent comparator treatments and also has a favourable safety and tolerability profile with more creatine phosphokinase (CK) elevations but significantly fewer renal side effects reported versus comparator treatments.(2) The favourable safety profile is an important factor in severely ill patients.

A recent survey suggests that there is delay in patients receiving appropriate treatment for MRSA in approximately 50% of cases.(7) Delaying effective treatment for 48 hours can increase mortality as well as result in longer hospital stays, thus increasing the burden on the healthcare system.(8-11) Since Daptomycin is equally effective in treating MSSA and MRSA, it represents an important new empirical treatment choice for patients with MRSA bacteraemia associated with right sided endocarditis or complicated soft skin tissue infections.(2)

About the product

Daptomycin was first approved in the UK in March 2006 and received a positive Scottish Medicines Consortium (SMC) recommendation for its use in treating complicated skin and soft tissue infections (cSSTIs) in March 2006.

Last month, The Committee for Medical Products for Human Use (CHMP) gave extended approval to daptomycin for the use in right-sided infective endocarditis (RIE) due to Staphylococcus aureus an
'/>"/>

SOURCE Novartis Pharmaceuticals UK Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The Genesis of Gendicine: The Story Behind the First Gene Therapy
2. Midwest life science stocks sizzle in a tepid first quarter
3. Morgridge Institute for Research seeks first CEO
4. Sonic Foundry reports first cash-positive quarter
5. Angel investors commit $12.7B in first half of `06
6. Aurora team implants Wisconsins first total artificial heart
7. First half of 2006 roundup: Big Pharma trumps biotech
8. GE announces first installation of Discovery VCT
9. GE Healthcare enjoys robust growth in first quarter
10. Madison asks for wireless bids; airport, downtown would be first
11. Tech Digest: Inacom, PKWare at Infosecurity, Firstlogic, Teklynx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014   ISN ... & Safety Performance Indicators publication series. With ... of activity reported in 2013 within its online contractor ... and safety key performance indicator (KPI) statistics. ... Clients, U.S. publication is available in two ...
(Date:12/17/2014)... Achim Noack has been named global vice ... this position, Noack will assist Jerry Stoller, CEO and ... strategy and supervise global marketing management and implementation of ... knowledge and experience in the crop protection industry,” says ... innovative thinking will be a great asset for Stoller ...
(Date:12/17/2014)... 2014 Gene synthesis and bioengineering ... entered into a technology access and services agreement ... DNA2.0’s proprietary protein engineering technology, known as “ProteinGPS®” ... are extremely excited that the global leader ADM ... proprietary bioengineering technology has now been validated through ...
(Date:12/17/2014)... , Dec. 17, 2014 Tigercat ... Phase 2 study evaluating the investigational oral NK-1 ... patients with severe, chronic itch who are unresponsive ... care, including topical steroids and antihistamines. ... in Visual Analog Scale (VAS) itch score from ...
Breaking Biology Technology:ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 2ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 3Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
... Dec. 3 Today, the International Society,for Stem Cell ... researchers, released new guidelines for the responsible,development of safe ... article that summarizes the Guidelines for the Clinical Translation,of ... the December issue of Cell,Stem Cell, the official affiliated ...
... Alternext US: NBS), which is pioneering the pre-disease collection,processing and ... announced that it has completed an above market financing for ... unit with each unit,consisting of one share of common stock ... $1.75 per share. , ...
... The William Lehman Injury Research,Center (WLIRC), ... the, University of Miami /Jackson Medical Center,s ... Advanced Technology Research Center (TATRC); the Army,Trauma ... (ATA) and,Qualcomm, through its Wireless Reach(TM) initiative, ...
Cached Biology Technology:The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy 2The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy 3The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy 4NeoStem Completes $500,000 Private Placement With Strategic Investor 2NeoStem Completes $500,000 Private Placement With Strategic Investor 3Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami 2Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami 3Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami 4Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami 5Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami 6
(Date:12/19/2014)... DUBLIN , Dec. 18, 2014 Research and ... addition of the "Micro Market Monitor: North America ... http://photos.prnewswire.com/prnh/20130307/600769 ... grow at a CAGR of 3.6% from 2014 to ... in this market, Canada is ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced ... the APAC Region 2015-2019"  report to their offering. ... this market is advances in technology. With continuous ... biometric solutions to the latest standard that meets ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... persist by depositing their genetic information (DNA) in the ... This prevents antiviral drugs from eliminating these viruses. But ... damaging the infected cell in the liver. In the ... the scientists report that now new therapeutic possibilities are ...
... temperature of our planet increases. This is particularly important ... (ectothermic), including insects. Their body temperature is ultimately determined ... to the speed and efficiency of their vital biological ... or frequency of extreme temperature conditions that have the ...
... by a Wits University scientist has overturned a long-standing ... distinct species in the course of evolution), suggesting that ... than was previously thought. Unlike humans and most ... genes in fact some plants, called polyploids, can ...
Cached Biology News:Degradation of viral DNA in the cell nucleus is opening up new treatment 2Extreme weather decides distribution of insects 2Extreme weather decides distribution of insects 3
...
Request Info...
The FliTrx Panning Kit is designed to simplify panning for protein-protein interactions with the FliTrx Random Peptide Display Library or the pFliTrx Peptide Display Vector....
... ISO 9001:2000 Certified USDA Research Registered OLAW ... Training AALAS Certified Technicians ... GLP Documentation Upon Request Focus ... for all your custom immunology service needs. ...
Biology Products: